Evidence map›Paper›PMID 29327452›Full record

ArticleJournal of tissue engineering and regenerative medicine2018

Regenerative effects of human embryonic stem cell-derived neural crest cells for treatment of peripheral nerve injury.

Iwan Jones, Liudmila N Novikova, Lev N Novikov, Monika Renardy, Andreas Ullrich, Mikael Wiberg, Leif Carlsson, Paul J Kingham

Open access · hybridAbstract read
In one paragraph

Article in Journal of tissue engineering and regenerative medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Current neuropharmacology · 2022
    Review
  13. Article
  14. Neural crest-like stem cells for tissue regeneration.Stem cells translational medicine · 2021
    Review
  15. Review
  16. Review
  17. Article
  18. Machine intelligence for nerve conduit design and production.Journal of biological engineering · 2020
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Iwan JonesUmeå Center for Molecular Medicine, Umeå University, Umeå, Sweden.
Liudmila N NovikovaLaboratory of Neural Repair and Cellular Therapy, Department of Integrative Medical Biology, Umeå University, Umeå, Sweden.
Lev N NovikovLaboratory of Neural Repair and Cellular Therapy, Department of Integrative Medical Biology, Umeå University, Umeå, Sweden.
Monika RenardyITV Denkendorf Product Service GmbH, Denkendorf, Germany.
Andreas UllrichITV Denkendorf Product Service GmbH, Denkendorf, Germany.
Mikael WibergLaboratory of Neural Repair and Cellular Therapy, Department of Integrative Medical Biology, Umeå University, Umeå, Sweden.
Leif CarlssonUmeå Center for Molecular Medicine, Umeå University, Umeå, Sweden.
Paul J KinghamLaboratory of Neural Repair and Cellular Therapy, Department of Integrative Medical Biology, Umeå University, Umeå, Sweden.ORCID 0000-0003-2596-5936
Umeå University · SEInstitute of Textile Technology and Process Engineering · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surgical intervention is the current gold standard treatment following peripheral nerve injury. However, this approach has limitations, and full recovery of both motor and sensory modalities often remains incomplete. The development of artificial nerve grafts that either complement or replace current surgical procedures is therefore of paramount importance. An essential component of artificial grafts is biodegradable conduits and transplanted cells that provide trophic support during the regenerative process. Neural crest cells are promising support cell candidates because they are the parent population to many peripheral nervous system lineages. In this study, neural crest cells were differentiated from human embryonic stem cells. The differentiated cells exhibited typical stellate morphology and protein expression signatures that were comparable with native neural crest. Conditioned media harvested from the differentiated cells contained a range of biologically active trophic factors and was able to stimulate in vitro neurite outgrowth. Differentiated neural crest cells were seeded into a biodegradable nerve conduit, and their regeneration potential was assessed in a rat sciatic nerve injury model. A robust regeneration front was observed across the entire width of the conduit seeded with the differentiated neural crest cells. Moreover, the up-regulation of several regeneration-related genes was observed within the dorsal root ganglion and spinal cord segments harvested from transplanted animals. Our results demonstrate that the differentiated neural crest cells are biologically active and provide trophic support to stimulate peripheral nerve regeneration. Differentiated neural crest cells are therefore promising supporting cell candidates to aid in peripheral nerve repair.

Indexed as

Nerve RegenerationNeural CrestSciatic NerveAnimalsCell Line, TumorFemaleHeterograftsHuman Embryonic Stem CellsHumansPeripheral Nerve InjuriesRatsRats, Sprague-Dawleyartificial nerve grafthuman embryonic stem cellsneural crest cellsperipheral nerve injuriesperipheral nervous system

Identifiers

PMID29327452
PMCPMC5947619
OpenAlexW2783677097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.